HALO
Halozyme TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
HALO Profile
Halozyme Therapeutics, Inc.
A biopharmaceutical company that develops recombinant human enzymes and novel oncology therapies for the tumor microenvironment
12390 El Camino Real, San Diego, California, 92130
--
Halozyme Therapeutics, Inc., is a biopharmaceutical company founded in 1998. In November 2007, the company was reorganized and registered in Delaware (previously registered in Nevada). The company is committed to the development and commercialization of innovative products. The company studies extracellular matrix, extracellular regions, including cell migration, signaling and survival. Over the years, the company has developed unique scientific expertise that allows it to pursue treatments that focus on environmental development.
